Microarray expression analysis in delayed cardioprotection: The effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK)

Molecular and Cellular Biochemistry

Volumn 360, Issue 1-2, 2012, Pages 353-362

  Solskov, Lasse ^a,b   Magnusson, Nils E ^a   Kristiansen, Steen B ^b   Jessen, Niels ^a   Nielsen, Torsten T ^b   Schmitz, Ole ^a   Bøtker, Hans Erik ^b   Lund, Sten ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AMPK; Cardioprotection; Delayed preconditioning; Genes; Microarray

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EXERCISE; GENE CONTROL; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART PROTECTION; MICROARRAY ANALYSIS; NEOPLASM; NONHUMAN; RAT; SINGLE DRUG DOSE;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES; GENETIC ASSOCIATION STUDIES; HEART VENTRICLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; METFORMIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RIBONUCLEOTIDES;

RATTUS;

EID: 83555172632     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1075-z     Document Type: Article

References (34)

1. PW Wilson RB D'Agostino D Levy AM Belanger H Silbershatz WB Kannel 1998 Prediction of coronary heart disease using risk factor categories Circulation 97 1837 1847 9603539 1:STN:280:DyaK1c3msVOjsA%3D%3D (Pubitemid 28213628)
2. C Ballantyne B Arroll J Shepherd 2005 Lipids and CVD management: towards a global consensus Eur Heart J 26 2224 2231 15972289 10.1093/eurheartj/ehi373 (Pubitemid 41541384)
3. CE Murry RB Jennings KA Reimer 1986 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1124 1136 3769170 10.1161/01.CIR.74.5.1124 1:STN:280:DyaL2s%2FivVKnuw%3D%3D (Pubitemid 17174962)
4. DJ Hausenloy PK Mwamure V Venugopal, et al. 2007 Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial Lancet 370 575 579 17707752 10.1016/S0140-6736(07)61296-3 (Pubitemid 47247853)
5. HE Botker R Kharbanda MR Schmidt, et al. 2010 Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 727 734 20189026 10.1016/S0140-6736(09)62001-8
6. R Bolli QH Li XL Tang, et al. 2007 The late phase of preconditioning and its natural clinical application-gene therapy Heart Fail Rev 12 189 199 17541820 10.1007/s10741-007-9031-4 1:CAS:528:DC%2BD2sXnvFKntL0%3D (Pubitemid 350176692)
7. WW Winder DG Hardie 1999 AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes Am J Physiol 277 E1 E10 10409121 1:CAS:528:DyaK1MXkslKgurg%3D (Pubitemid 29356721)
8. NB Ruderman AK Saha D Vavvas LA Witters 1999 Malonyl-CoA, fuel sensing, and insulin resistance Am J Physiol 276 E1 E18 9886945 1:CAS:528: DyaK1MXntlantw%3D%3D (Pubitemid 29065588)
9. G Zhou R Myers Y Li, et al. 2001 Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 1167 1174 11602624 1:CAS:528:DC%2BD3MXns1ChsL4%3D (Pubitemid 32995375)
10. N Musi MF Hirshman J Nygren, et al. 2002 Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes Diabetes 51 2074 2081 12086935 10.2337/diabetes.51.7.2074 1:CAS:528:DC%2BD38Xlt1WltrY%3D (Pubitemid 34729010)
11. Y Xing N Musi N Fujii, et al. 2003 Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative {alpha}2 subunit of AMP-activated protein kinase J Biol Chem 278 28372 28377 12766162 10.1074/jbc.M303521200 1:CAS:528:DC%2BD3sXlsl2ntrs%3D (Pubitemid 36935737)
12. RR Russell III J Li DL Coven, et al. 2004 AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 495 503 15314686 1:CAS:528: DC%2BD2cXmvVelsr4%3D (Pubitemid 39572099)
13. Y Nishino T Miura T Miki, et al. 2004 Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc Res 61 610 619 14962491 10.1016/j.cardiores. 2003.10.022 1:CAS:528:DC%2BD2cXhtFWmsbg%3D (Pubitemid 38210166)
14. L Solskov B Lofgren SB Kristiansen, et al. 2008 Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration Basic Clin Pharmacol Toxicol 103 82 87 18484962 10.1111/j.1742-7843.2008.00234.x 1:CAS:528:DC%2BD1cXotlKisb0%3D (Pubitemid 351874532)
15. Kristiansen SB, Jensen LS, Jessen N et al. (2009) 5-Aminoimidazole-4- carboxamide-1-beta- D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre- conditioning: potential role of AMP-activated protein kinase. Basic Clin Pharmacol Toxicol 2009 Jul 105(1):10-6 Epub 2009 Apr 8
16. T Thykjaer C Workman M Kruhoffer, et al. 2001 Identification of gene expression patterns in superficial and invasive human bladder cancer Cancer Res 61 2492 2499 11289120 1:CAS:528:DC%2BD3MXisVSlu7c%3D (Pubitemid 32685829)
17. R Bolli 2000 The late phase of preconditioning Circ Res 87 972 983 11090541 1:CAS:528:DC%2BD3cXoslygsLc%3D
18. PI Bonta TW Pols CJ de Vries 2007 NR4A nuclear receptors in atherosclerosis and vein-graft disease Trends Cardiovasc Med 17 105 111 17418373 10.1016/j.tcm.2007.02.001 1:CAS:528:DC%2BD2sXjvFGgtb8%3D (Pubitemid 46518167)
19. Y Fu L Luo N Luo X Zhu WT Garvey 2007 NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance J Biol Chem 282 31525 31533 17785466 10.1074/jbc.M701132200 1:CAS:528:DC%2BD2sXhtFykurbP (Pubitemid 350044839)
20. AC Zambon EL McDearmon N Salomonis, et al. 2003 Time- and exercise-dependent gene regulation in human skeletal muscle Genome Biol 4 R61 14519196 10.1186/gb-2003-4-10-r61
21. DJ Mahoney G Parise S Melov A Safdar MA Tarnopolsky 2005 Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise FASEB J 19 1498 1500 15985525 1:CAS:528:DC%2BD2MXpvFKhtbo%3D (Pubitemid 41279010)
22. Kawasaki E, Hokari F, Sasaki M, Sakai A, Koshinaka K, Kawanaka K (2009) Role of local muscle contractile activity in the exercise-induced increase in NR4A receptors mRNA expression. J Appl Physiol 2009 Jun 106(6):1826-31
23. T Hehlgans K Pfeffer 2005 The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games Immunology 115 1 20 15819693 10.1111/j.1365-2567.2005.02143.x 1:CAS:528:DC%2BD2MXjvFaqtrs%3D (Pubitemid 40598088)
24. SR Wiley JA Winkles 2003 TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor Cytokine Growth Factor Rev 14 241 249 12787562 10.1016/S1359-6101(03)00019-4 1:CAS:528:DC%2BD3sXkt1Ghsrk%3D (Pubitemid 36693144)
25. T Hamid Y Gu RV Ortines, et al. 2009 Divergent tumor necrosis factor receptor-rela ted remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation Circulation 119 1386 1397 19255345 10.1161/CIRCULATIONAHA.108.802918 1:CAS:528:DC%2BD1MXivVentbo%3D
26. D Closa Y Motoo JL Iovanna 2007 Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine World J Gastroenterol 13 170 174 17226896 1:CAS:528:DC%2BD2sXitlequ7Y%3D (Pubitemid 46231320)
27. BA Barron 2000 Cardiac opioids Proc Soc Exp Biol Med 224 1 7 10782040 10.1046/j.1525-1373.2000.22358.x 1:CAS:528:DC%2BD3cXislyqt78%3D
28. R Fryer J Auchampach G Gross 2002 Therapeutic receptor targets of ischemic preconditioning Cardiovasc Res 55 520 12160948 10.1016/S0008-6363(02) 00316-4 1:CAS:528:DC%2BD38XlvVWnsr0%3D (Pubitemid 34874946)
29. GF Baxter P Ferdinandy 2001 Delayed preconditioning of myocardium: current perspectives Basic Res Cardiol 96 329 344 11518189 10.1007/s003950170041 1:CAS:528:DC%2BD3MXmtF2qu7s%3D (Pubitemid 32700570)
30. T Yanazume T Morimoto H Wada T Kawamura K Hasegawa 2003 Biological role of p300 in cardiac myocytes Mol Cell Biochem 248 115 119 12870662 10.1023/A:1024132217870 1:CAS:528:DC%2BD3sXksFWnsLg%3D (Pubitemid 36833648)
31. Y Wang C Barbacioru F Hyland W Xiao KL Hunkapiller 2006 Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays BMC Genomics 7 59 74 16551369 10.1186/1471-2164-7-59
32. DJ Hausenloy DM Yellon 2010 The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther 24 235 254 20496105 10.1007/s10557-010- 6237-9
33. Magnusson NE, Cardozo AK, Kruhoffer M, Eizirik DL, Ørntoft TF, Jensen JL (2005) Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta- cell apoptosis. BMC Bioinformatics 29:6:311
34. NE Magnusson A Larsen J Rungby M Kruhoffer TF Ørntoft M Stoltenberg 2005 Gene expression changes induced by bismuth in a macrophage cell line Cell Tissue Res 321 195 210 15912405 10.1007/s00441-005-1103-y 1:CAS:528:DC%2BD2MXmt12qsrk%3D (Pubitemid 41127027)